top of page
Private Equity's Impact on Urology Practices with Dr. Benjamin Lowentritt, Dr. Ruchika Talwar on the BackTable Urology Podcast
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 315  •  10 Jul 2026

Private Equity's Impact on Urology Practices

What opportunities and challenges does private equity bring to urology practices, and how can physicians engage in ways that strengthen their practice and preserve clinical priorities? On this episode of BackTable Urology, Dr. Ruchika Talwar interviews Dr. Benjamin Lowentritt of Chesapeake Urology and United Urology Group to unpack the realities of private equity involvement in medicine. They discuss the motivations behind consolidation, the role of management services organizations, and strategies for building mutually beneficial partnerships while upholding physician autonomy and patient care.

Timestamps

00:00 - Introduction
02:58 - Why Urology Drew Private Equity
07:06 - Bad Headlines vs. Reality
11:14 - MSOs and Contracts Explained
15:24 - Timelines and After Private Equity
22:47 - Efficiency and Autonomy Fears
27:15 - Why Private Equity Gets Vilified
31:23 - Young Urologist Job Market
35:42 - Advice for New Grads
40:26 - Urology in 2035 and Fair Critiques of Private Equity
44:40 - Closing Thoughts

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

Dr. Lowentritt outlines the history of private equity in healthcare, noting that consolidation predated private equity and was driven by payer and hospital market power, reimbursement pressure, administrative burden, staffing, and capital needs. He distinguishes private equity’s role in hospitals from physician practice management, describing management services organization (MSOs) as structures that handle back-office functions and provide capital while preserving physician control over patient care and local governance. He also discusses private equity’s limited investment timeline, shaped by the ultimate goal of selling a profitable company, and potential end-states such as acquisition or public ownership, reflecting on his own experiences with United Urology’s acquisition. The conversation further explores recruiting new graduates, evolving partner tracks, mentorship, and maintaining physician leadership to preserve independent practice.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page